Efforts toward synthesis of oligonucleotides for commercialization

Nucleosides and Nucleotides

Volumn 16, Issue 7-9, 1997, Pages 1617-1620

  Andrade, Mark ^a   Scozzari, Anthony S ^a   Cole, Douglas L ^a   Ravikumar, Vasulinga T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; CGP 69846A; FOMIVIRSEN; ISIS 2503; ISIS 3521; ISIS 5320; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CANCER; CONFERENCE PAPER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; RETINITIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030720856     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319708006239     Document Type: Conference Paper

References (3)

1. Crooke, S. T. In Burger's Medicinal Chemistry and Drug Discovery; M. E. Wolff, Ed.; John Wiley & Sons: New York, 1995; Vol. 1; pp 863.
2. Ravikumar, V. T.; Andrade, M.; Wyrzykiewicz, T. K.; Scozzari, A.; Cole, D. L. Nucleosides Nucleotides, 1995, 14, 1219.
3. D. L. Cole, XII International Round Table: Nucleosides, Nucleotides and Their Applications, La Jolla, September 15-19, 1996.